You are here

US awards new US$628m contract to boost output of potential Covid-19 vaccine

file7arsc92a7ixvi2549nz.jpg
The US government on Monday entered into a US$628 million contract with drugmaker Emergent BioSolutions to boost manufacturing capacity for a potential Covid-19 vaccine.

[WASHINGTON] The US government on Monday entered into a US$628 million contract with drugmaker Emergent BioSolutions to boost manufacturing capacity for a potential Covid-19 vaccine.

As drugmakers race to develop vaccines, tests and therapies for the disease, the United States is looking...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes